Helena Chmura Kraemer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Helena Chmura Kraemer has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Vyjeyanthi S. Periyakoil
Stanford University School of Medicine Stanford CA USA
3 shared publications David J. Kupfer
Department of Psychiatry University of Pittsburgh School of Medicine Pittsburgh PA USA
2 shared publicationsEllen Frank
Department of Psychiatry University of Pittsburgh School of Medicine Pittsburgh PA USA
2 shared publications- Eric Neri
Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, United States
2 shared publications - Javaid I. Sheikh
AI Center for Precision Health, Weill Cornell Medicine-Qatar, Doha, Qatar
2 shared publications - Jerome A. Yesavage
Department of Veterans Affairs Health Care System, Palo Alto, CA, USA
2 shared publications
Latest Publications
- Open Access
- 10 March 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Improving the discernment of microaggressions reported by women in medicine: Outcomes of a web-based educational intervention (Preprint)
BACKGROUND Women in medicine report frequently encountering microaggressions that contribute to burnout, diminished belonging, and attrition, yet brief, scalable trainings to improve recognition skills are understudied. OBJECTIVE This study reports the impact of a 90-minute, virtual, video-based course impact on health professionals’ ability to discern microaggressions from non-microaggressive encounters using a performance-based assessment. METHODS 304 health professionals across completed a pretest with four paired microaggression (MA) and non-microaggression (NMA) videos, a virtual 90-minute course (“Microaggressions have macro-consequences”) grounded in Kolb’s experiential learning cycle, and a posttest with four new MA–NMA pairs. After each video, participants rated microaggressive content on a 7-point Likert scale, which was used to calculate a Microaggression Discernment Score. The primary outcome was change in this score from pre- to posttest. Exploratory quantitative recursive partitioning examined associations between change scores, baseline discernment, and demographics. RESULTS Participants included physicians (31.9%), nurses (30.3%), and other health professionals (37.9%), most of whom identified as female (62.7%). Overall, 66.1% demonstrated improved discernment, 13.5% showed no change, and 20.4% regressed; the median percent change in correct identification was 12.5% (interquartile range 0.0–33.3; range −83.3 to 87.5). Baseline discernment score was the primary predictor of improvement: 80.9% of participants with intermediate pretest scores improved, compared with 41.0% with low and 41.4% with high pretest scores. CONCLUSIONS A virtual, scenario-based, video training was associated with meaningful improvements in health professionals’ ability to discern microaggressions from non-microaggressive encounters, particularly among those with intermediate baseline skills. Performance-based recognition measures can help institutions target and track microaggression education as part of broader efforts to foster psychologically safe, respectful learning and practice environments for women in medicine.
- 10 March 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessImproving the discernment of microaggressions reported by women in medicine: Outcomes of a web-based educational intervention (Preprint)
BACKGROUND Women in medicine report frequently encountering microaggressions that contribute to burnout, diminished belonging, and attrition, yet brief, scalable trainings to improve recognition skills are understudied. OBJECTIVE This study reports the impact of a 90-minute, virtual, video-based course impact on health professionals’ ability to discern microaggressions from non-microaggressive encounters using a performance-based assessment. METHODS 304 health professionals across completed a pretest with four paired microaggression (MA) and non-microaggression (NMA) videos, a virtual 90-minute course (“Microaggressions have macro-consequences”) grounded in Kolb’s experiential learning cycle, and a posttest with four new MA–NMA pairs. After each video, participants rated microaggressive content on a 7-point Likert scale, which was used to calculate a Microaggression Discernment Score. The primary outcome was change in this score from pre- to posttest. Exploratory quantitative recursive partitioning examined associations between change scores, baseline discernment, and demographics. RESULTS Participants included physicians (31.9%), nurses (30.3%), and other health professionals (37.9%), most of whom identified as female (62.7%). Overall, 66.1% demonstrated improved discernment, 13.5% showed no change, and 20.4% regressed; the median percent change in correct identification was 12.5% (interquartile range 0.0–33.3; range −83.3 to 87.5). Baseline discernment score was the primary predictor of improvement: 80.9% of participants with intermediate pretest scores improved, compared with 41.0% with low and 41.4% with high pretest scores. CONCLUSIONS A virtual, scenario-based, video training was associated with meaningful improvements in health professionals’ ability to discern microaggressions from non-microaggressive encounters, particularly among those with intermediate baseline skills. Performance-based recognition measures can help institutions target and track microaggression education as part of broader efforts to foster psychologically safe, respectful learning and practice environments for women in medicine.
- Open Access
- 24 December 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e75082
Virtual, Nurse-Led Early Primary Palliative Care Intervention (ELICIT) for Community-Dwelling Older Adults With Cognitive Impairment: Protocol for a Randomized Controlled Trial
Background: Although dementia is a serious illness that progresses over many years, little is known about the primary palliative care needs of individuals who have it, especially those living in the community. Objective: This trial aims to test the impact of a virtual, nurse-led early primary palliative care intervention (ELICIT) on older adults living in the community who are chronically ill and have a diagnosis of cognitive impairment or are at risk of it. Methods: A total of 200 community-dwelling older adults who were chronically ill and had varying degrees of cognitive impairment were recruited and randomized to either usual care or usual care + a virtual, nurse-led ELICIT. For both arms, we will track the number of participants who (1) report supportive care needs to the blinded evaluators and (2) complete conversations on goals of care and document advance directives and the Physician Orders for Life-Sustaining Treatment form in the electronic health record. We will also track their end-of-life resource use and the percentage of participants who receive goal-concordant care. Changes in Edmonton Symptom Assessment Scale, Patient Activation Measure, and Quality of Life in Alzheimer’s Disease scores will be tracked and analyzed. Results: As of October 2025, we have recruited 200 participants. We are following all study participants on an ongoing basis to determine whether they received goal-concordant care at the end of life and their resource use patterns. We hypothesize that, compared to the usual care arm, more participants in the intervention arm will (1) express supportive care needs to the blinded evaluators, (2) complete goals of care conversations, document advance care planning, and (3) have higher levels of goal-concordant care and lower end-of-life resource use. Conclusions: The identification of the primary palliative care needs of community-dwelling older adults who are chronically ill and have various levels of cognitive impairment will help refine the intervention and enable trained nurses to provide virtual early primary palliative care within the scope of nursing.
- 24 December 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e75082
Open AccessVirtual, Nurse-Led Early Primary Palliative Care Intervention (ELICIT) for Community-Dwelling Older Adults With Cognitive Impairment: Protocol for a Randomized Controlled Trial
Background: Although dementia is a serious illness that progresses over many years, little is known about the primary palliative care needs of individuals who have it, especially those living in the community. Objective: This trial aims to test the impact of a virtual, nurse-led early primary palliative care intervention (ELICIT) on older adults living in the community who are chronically ill and have a diagnosis of cognitive impairment or are at risk of it. Methods: A total of 200 community-dwelling older adults who were chronically ill and had varying degrees of cognitive impairment were recruited and randomized to either usual care or usual care + a virtual, nurse-led ELICIT. For both arms, we will track the number of participants who (1) report supportive care needs to the blinded evaluators and (2) complete conversations on goals of care and document advance directives and the Physician Orders for Life-Sustaining Treatment form in the electronic health record. We will also track their end-of-life resource use and the percentage of participants who receive goal-concordant care. Changes in Edmonton Symptom Assessment Scale, Patient Activation Measure, and Quality of Life in Alzheimer’s Disease scores will be tracked and analyzed. Results: As of October 2025, we have recruited 200 participants. We are following all study participants on an ongoing basis to determine whether they received goal-concordant care at the end of life and their resource use patterns. We hypothesize that, compared to the usual care arm, more participants in the intervention arm will (1) express supportive care needs to the blinded evaluators, (2) complete goals of care conversations, document advance care planning, and (3) have higher levels of goal-concordant care and lower end-of-life resource use. Conclusions: The identification of the primary palliative care needs of community-dwelling older adults who are chronically ill and have various levels of cognitive impairment will help refine the intervention and enable trained nurses to provide virtual early primary palliative care within the scope of nursing.
- 14 February 2024
- Published by Wiley in International Journal of Eating Disorders
- Vol. 57 (5) , 1138-1140
Envisioning an improved research strategy for detecting moderators/mediators in intervention studies: A commentary on McClure et al.
The goal of moderator/mediator research in treatment evaluation is to provide guidance to clinicians to choose the best treatment for each patient with a disorder (moderators), and to advise on its optimal protocol or implementation (mediators): personalized/precision medicine. McClure et al. report a systematic review of studies addressing moderators/mediators of the treatment effect of digital interventions for eating disorders, finding no robust moderators or mediators. They attribute this failure to methodological problems, an assessment with which I concur. The focus of this discussion is to clarify which methodological approaches are not likely to be successful, and to envision a research strategy encompassing both hypothesis‐generating (exploratory) and hypothesis‐testing approaches likely to produce better results not only for eating disorders, but also for all medical treatments.
- 14 February 2024
- Published by Wiley in International Journal of Eating Disorders
- Vol. 57 (5) , 1138-1140
Envisioning an improved research strategy for detecting moderators/mediators in intervention studies: A commentary on McClure et al.
The goal of moderator/mediator research in treatment evaluation is to provide guidance to clinicians to choose the best treatment for each patient with a disorder (moderators), and to advise on its optimal protocol or implementation (mediators): personalized/precision medicine. McClure et al. report a systematic review of studies addressing moderators/mediators of the treatment effect of digital interventions for eating disorders, finding no robust moderators or mediators. They attribute this failure to methodological problems, an assessment with which I concur. The focus of this discussion is to clarify which methodological approaches are not likely to be successful, and to envision a research strategy encompassing both hypothesis‐generating (exploratory) and hypothesis‐testing approaches likely to produce better results not only for eating disorders, but also for all medical treatments.
- 8 April 2022
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 150, 279-281
Letter to the Editor: Caution warranted when interpreting registry studies of medication. A response to Boland et al. (2020)
- 8 April 2022
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 150, 279-281
Letter to the Editor: Caution warranted when interpreting registry studies of medication. A response to Boland et al. (2020)
- 23 November 2020
- Published by Taylor & Francis
- p. 705-718
"Rules" of Evidence in Assessing the Efficacy and Effectiveness of Treatments
The randomized clinical trial (RCT) approach is an ever-evolving compilation of strategies designed to minimize the probability of bias and to maximize the probability of reproducibility and the impact of the results. The genesis of the RCT is ancient, harking back to at least the controlled test of limes for scurvy prevention in the 1700s in the British Navy. A RCT done with only men does not produce results that necessarily generalize to women or children. The causal effect of treatment on a particular patient is defined as the difference in response when that patient is given the treatment versus when the patient is not. Researchers may simply miscalculate, for example, by doing power calculations based on the effect sizes they hope or expect to see, which are typically much more optimistic than the lower limit of clinical significance on which power calculations should be based.
- 23 November 2020
- Published by Taylor & Francis
- p. 705-718
"Rules" of Evidence in Assessing the Efficacy and Effectiveness of Treatments
The randomized clinical trial (RCT) approach is an ever-evolving compilation of strategies designed to minimize the probability of bias and to maximize the probability of reproducibility and the impact of the results. The genesis of the RCT is ancient, harking back to at least the controlled test of limes for scurvy prevention in the 1700s in the British Navy. A RCT done with only men does not produce results that necessarily generalize to women or children. The causal effect of treatment on a particular patient is defined as the difference in response when that patient is given the treatment versus when the patient is not. Researchers may simply miscalculate, for example, by doing power calculations based on the effect sizes they hope or expect to see, which are typically much more optimistic than the lower limit of clinical significance on which power calculations should be based.
- 1 February 2020
- Published by Wiley in International Journal of Eating Disorders
- Vol. 53 (2) , 302-308
Wrangling with p-values versus effect sizes to improve medical decision-making: A tutorial
The most pervasive and damaging myth in clinical research is that the smaller the p-value, the stronger the hypothesis. In reality, the p-value primarily reflects the quality of research design decisions. The most common proposal to avoid misleading conclusions from clinical research requires the appropriate use of effect sizes, but which effect size, used when and how, is an open question. A solution is proposed for perhaps the most common problem in clinical research, the comparison between two populations, for example, comparison of two treatments in a randomized clinical trial or comparison of high risk versus low risk individuals in an epidemiological study: the success rate difference or equivalently the number needed to treat/take (NNT).
- 1 February 2020
- Published by Wiley in International Journal of Eating Disorders
- Vol. 53 (2) , 302-308
Wrangling with p-values versus effect sizes to improve medical decision-making: A tutorial
The most pervasive and damaging myth in clinical research is that the smaller the p-value, the stronger the hypothesis. In reality, the p-value primarily reflects the quality of research design decisions. The most common proposal to avoid misleading conclusions from clinical research requires the appropriate use of effect sizes, but which effect size, used when and how, is an open question. A solution is proposed for perhaps the most common problem in clinical research, the comparison between two populations, for example, comparison of two treatments in a randomized clinical trial or comparison of high risk versus low risk individuals in an epidemiological study: the success rate difference or equivalently the number needed to treat/take (NNT).
- Open Access
- 1 December 2018
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 21 (12) , 1749-1754
A Three-Step Letter Advance Directive Procedure to Facilitate Patient-Proxy Alignment in Advance Care Planning
Background: Little is known about the extent of alignment between hematopoietic stem cell transplant (HSCT) patients and their healthcare proxies with respect to advance care planning (ACP). Aim: To determine if a structured three-step process using the letter advance directive (LAD) could (1) allow for the differences in opinion between patient–proxy dyads to surface and (2) help bridge preexisting discordance about specific treatment choices. Design: Blinded to each other, the HSCT patient (LAD-1) and proxy (LAD-2) each completed the LAD (step 1). They unmasked, compared LAD-1 and LAD-2, and discussed their choices (step 2). They completed a final letter directive (LAD-3) by consensus (step 3). Settings/Participants: Convenience sample of eighty dyads (patient and proxy) at a regional HSCT referral center. Results: The mean patient–proxy concordance was 72.9% for the 12 questions in the LAD. Wanting to be pain free at the end of life was the statement with the most amount of agreement (88.75% in LAD-1, 91.25% in LAD-2, and 90% in LAD-3). Patient–proxy dyads had notable discordance related to specific treatments. The highest discordance was related to ventilator support (46.3% of patients refused it, while 58.8% of proxies refused on behalf of the patient). Overall, proxies were more likely than patients to opt in for dialyses and hospice care but more likely to opt out for cardiac resuscitation and sedation to palliate refractory symptoms. On open discussion, patient–proxy discordance mostly resolved in favor of the patient. Conclusions: The ACP process should allow for patient–proxy differences to surface, facilitate a discussion about the granular details with the goal of reaching consensus. Our three-step approach using the LAD is an effective way to identify areas of patient–proxy concordance and discordance about specific treatment preferences. A structured patient–proxy discussion using the LAD helped reconcile discordance and most often in favor of a patient's original wishes.
- 1 December 2018
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 21 (12) , 1749-1754
Open AccessA Three-Step Letter Advance Directive Procedure to Facilitate Patient-Proxy Alignment in Advance Care Planning
Background: Little is known about the extent of alignment between hematopoietic stem cell transplant (HSCT) patients and their healthcare proxies with respect to advance care planning (ACP). Aim: To determine if a structured three-step process using the letter advance directive (LAD) could (1) allow for the differences in opinion between patient–proxy dyads to surface and (2) help bridge preexisting discordance about specific treatment choices. Design: Blinded to each other, the HSCT patient (LAD-1) and proxy (LAD-2) each completed the LAD (step 1). They unmasked, compared LAD-1 and LAD-2, and discussed their choices (step 2). They completed a final letter directive (LAD-3) by consensus (step 3). Settings/Participants: Convenience sample of eighty dyads (patient and proxy) at a regional HSCT referral center. Results: The mean patient–proxy concordance was 72.9% for the 12 questions in the LAD. Wanting to be pain free at the end of life was the statement with the most amount of agreement (88.75% in LAD-1, 91.25% in LAD-2, and 90% in LAD-3). Patient–proxy dyads had notable discordance related to specific treatments. The highest discordance was related to ventilator support (46.3% of patients refused it, while 58.8% of proxies refused on behalf of the patient). Overall, proxies were more likely than patients to opt in for dialyses and hospice care but more likely to opt out for cardiac resuscitation and sedation to palliate refractory symptoms. On open discussion, patient–proxy discordance mostly resolved in favor of the patient. Conclusions: The ACP process should allow for patient–proxy differences to surface, facilitate a discussion about the granular details with the goal of reaching consensus. Our three-step approach using the LAD is an effective way to identify areas of patient–proxy concordance and discordance about specific treatment preferences. A structured patient–proxy discussion using the LAD helped reconcile discordance and most often in favor of a patient's original wishes.
- Open Access
- 21 December 2017
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 17 (1) , 1-9
The development of CHAMP: a checklist for the appraisal of moderators and predictors
Personalized healthcare relies on the identification of factors explaining why individuals respond differently to the same intervention. Analyses identifying such factors, so called predictors and moderators, have their own set of assumptions and limitations which, when violated, can result in misleading claims, and incorrect actions. The aim of this study was to develop a checklist for critically appraising the results of predictor and moderator analyses by combining recommendations from published guidelines and experts in the field. Candidate criteria for the checklist were retrieved through systematic searches of the literature. These criteria were evaluated for appropriateness using a Delphi procedure. Two Delphi rounds yielded a pilot checklist, which was tested on a set of papers included in a systematic review on reinforced home-based palliative care. The results of the pilot informed a third Delphi round, which served to finalize the checklist. Forty-nine appraisal criteria were identified in the literature. Feedback was obtained from fourteen experts from (bio)statistics, epidemiology and other associated fields elicited via three Delphi rounds. Additional feedback from other researchers was collected in a pilot test. The final version of our checklist included seventeen criteria, covering the design (e.g. a priori plausibility), analysis (e.g. use of interaction tests) and results (e.g. complete reporting) of moderator and predictor analysis, together with the transferability of the results (e.g. clinical importance). There are criteria both for individual papers and for bodies of evidence. The proposed checklist can be used for critical appraisal of reported moderator and predictor effects, as assessed in randomized or non-randomized studies using individual participant or aggregate data. This checklist is accompanied by a user’s guide to facilitate implementation. Its future use across a wide variety of research domains and study types will provide insights about its usability and feasibility.
- 21 December 2017
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 17 (1) , 1-9
Open AccessThe development of CHAMP: a checklist for the appraisal of moderators and predictors
Personalized healthcare relies on the identification of factors explaining why individuals respond differently to the same intervention. Analyses identifying such factors, so called predictors and moderators, have their own set of assumptions and limitations which, when violated, can result in misleading claims, and incorrect actions. The aim of this study was to develop a checklist for critically appraising the results of predictor and moderator analyses by combining recommendations from published guidelines and experts in the field. Candidate criteria for the checklist were retrieved through systematic searches of the literature. These criteria were evaluated for appropriateness using a Delphi procedure. Two Delphi rounds yielded a pilot checklist, which was tested on a set of papers included in a systematic review on reinforced home-based palliative care. The results of the pilot informed a third Delphi round, which served to finalize the checklist. Forty-nine appraisal criteria were identified in the literature. Feedback was obtained from fourteen experts from (bio)statistics, epidemiology and other associated fields elicited via three Delphi rounds. Additional feedback from other researchers was collected in a pilot test. The final version of our checklist included seventeen criteria, covering the design (e.g. a priori plausibility), analysis (e.g. use of interaction tests) and results (e.g. complete reporting) of moderator and predictor analysis, together with the transferability of the results (e.g. clinical importance). There are criteria both for individual papers and for bodies of evidence. The proposed checklist can be used for critical appraisal of reported moderator and predictor effects, as assessed in randomized or non-randomized studies using individual participant or aggregate data. This checklist is accompanied by a user’s guide to facilitate implementation. Its future use across a wide variety of research domains and study types will provide insights about its usability and feasibility.
- 21 June 2017
- Published by Springer Nature
- p. 544-547
Moderators and Mediators
- 1 March 2017
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 86, 26-33
Handling clinical comorbidity in randomized clinical trials in psychiatry
- 1 March 2017
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 86, 26-33
Handling clinical comorbidity in randomized clinical trials in psychiatry